Back to Trades
Aghazadeh Behzad
Director10% OwnerCIK 0001701815
Profile
- Filings
- 4
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 2
- Active
- 2026
Aghazadeh Behzad, Director, 10% Owner, has filed 4 SEC reports (2026), spread across 2 companies, totaling $36.6M in disclosed volume. Weighing $36.3M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $36.3M in Scribe Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 28 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director, 10% Owner | Buy | $36.3M |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director | Other | $0 |
| Jun 15 | WHWK Whitehawk Therapeutics, Inc. | Aghazadeh Behzad | Insider | Award | $158.2K |
4 filings